The full effect of the UK's vote to leave the European Union will certainly take time to materialise. However, growing concerns in the life sciences community are already palpable and the questions are many. In this section, we look at some of the issues facing life sciences sector in a post-Brexit environment.

13 March 2019
IP incentives for medicinal products in the UK in the event of a ‘no-deal’ Brexit

With less than a month to go before Brexit day, and with no certainty on...

25 February 2019
Brexit is not frustrating

On 20 February 2019 the High Court ruled against the European Medicines Agency (EMA) in...

10 January 2019
UK Government’s Further Guidance for the Life Sciences Sector on a No Deal Brexit – Key Considerations

With less than a week before MPs in the House of Commons vote on Theresa...

16 November 2018
An Agreement not yet agreed: the potential impact of the proposed Withdrawal Agreement on the regulation of medicines and medical devices

In light of a string of high-profile resignations, it is questionable whether the Government’s proposed EU...

24 August 2018
Important update for the pharmaceutical and medical device sector - UK Government Guidance on how to prepare for “no deal” Brexit

On 23 August 2018, the UK Government published 25 notices (published as part of a series...

30 July 2018
EMA advises pharma companies to be proactive ahead of Brexit

In June 2018 the EMA published an update to their Questions and Answers regarding the...

17 July 2018
Brexit White Paper: key points for the life sciences industry

On Thursday 12 July, the UK Government published its much anticipated White Paper setting out...

4 July 2018
Funding for UK Research and Innovation Post-Brexit: Hope on the Horizon?

An update on the UK’s participation in Horizon 2020 and its successor Horizon Europe

17 May 2018
European Commission addresses SPCs & Brexit

On 27 April 2018, the European Commission published a notice to stakeholders on the impact...

5 April 2018
We have our transition period for goods but what about the regulations? How the life sciences industry may be affected by Brexit

The European Commission published a Draft Withdrawal Agreement on 19 March 2018. The Agreement is likely...

31 January 2018
EMA’s final relocation delayed until at least November 2019

On the 20th of November 2017, Amsterdam beat Milan to become the European Medicines Agency’s new...

17 January 2018
Impact of Brexit on International Data Transfer Mechanisms

Currently in relation to personal data, and particularly health data, there are a number of...